Apolipoprotein E inhibits neointimal hyperplasia after arterial injury in mice.
The potential cytostatic function of apolipoprotein (apo) E in vivo was explored by measuring neointimal hyperplasia in response to vascular injury in apoE-deficient and apoE-overexpressing transgenic mice. Results showed a significant increase in medial thickness, medial area, and neointimal formation after vascular injury in both apoE knockout and wild-type C57BL/6 mice. Immunochemical analysis with smooth muscle alpha-actin-specific antibodies revealed that the neointima contained proliferating smooth muscle cells. Neointimal area was 3.4-fold greater, and the intima/medial ratio as well as stenotic luminal area was more pronounced in apoE(-/-) mice than those observed in control mice (P < 0.05). The human apoE3 transgenic mice in FVB/N genetic background were then used to verify a direct effect of apoE in protection against neointimal hyperplasia in response to mechanically induced vascular injury. Results showed that neointimal area was reduced threefold to fourfold in mice overexpressing the human apoE3 transgene (P < 0.05). Importantly, suppression of neointimal formation in the apoE transgenic mice also abolished the luminal stenosis observed in their nontransgenic FVB/N counterparts. These results documented a direct role of apoE in modulating vascular response to injury, suggesting that increasing apoE level may be beneficial in protection against restenosis after vascular surgery.
Zhu
B
B
Department of Pathology and Laboratory Medicine, University of Cincinnati College of Medicine. Children's Hospital Research Foundation, Cincinnati, Ohio, USA.
Kuhel
D G
DG
Witte
D P
DP
Hui
D Y
DY
D000818:Animals; D053318:Apolipoprotein E3; D001057:Apolipoproteins E / Q000172:deficiency / Q000235:genetics / Q000494:pharmacology / Q000502:physiology*; D002339:Carotid Arteries / Q000187:drug effects / Q000473:pathology; D020212:Carotid Artery Injuries / Q000150:complications / Q000473:pathology*; D016893:Carotid Stenosis / Q000209:etiology / Q000473:pathology; D006801:Humans; D006965:Hyperplasia / Q000517:prevention & control; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D018345:Mice, Knockout / Q000235:genetics; D008822:Mice, Transgenic / Q000235:genetics; D017539:Tunica Intima / Q000473:pathology*
D053318:Apolipoprotein E3; D001057:Apolipoproteins E